Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic pathology in industrialized countries, affecting about 25% of the general population. NAFLD is a benign condition, however, it could evolve toward more serious diseases, including non-alcoholic steatohepatitis (NASH), fibrosis, cir...
Guardado en:
Autores principales: | Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5f97a1e3ef748ca8078245b8e2cf650 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating noncoding RNAs as early predictive biomarkers in preeclampsia: a diagnostic meta-analysis
por: Sha Su, et al.
Publicado: (2021) -
The Emerging Role of Non-Coding RNAs in Osteoarthritis
por: Soudeh Ghafouri-Fard, et al.
Publicado: (2021) -
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
por: Miguel Hueso, et al.
Publicado: (2021) -
Circulatory <i>Endothelin 1-</i>Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study
por: Reda Albadawy, et al.
Publicado: (2021) -
Long noncoding RNAs and Alzheimer's disease
por: Luo Q, et al.
Publicado: (2016)